Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
42201038
Type of Stem Cell Treatment:
Diseases:
Chronic Myeloid Leukaemia (CML)
Short title:
Primary objective:
Key inclusion criteria:
>18years old; allogeneic HSCT; CML; Dasatinib or Nilotinib
Country:
Principal investigator:
Michael Schleuning
EBMT Study coordinator:
Jennifer Hoek